SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004503
Filing Date
2018-05-09
Accepted
2018-05-09 16:47:07
Documents
116
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bgne-20180331x10q.htm 10-Q 2102959
2 EX-31.1 bgne-20180331ex3115cb836.htm EX-31.1 21774
3 EX-31.2 bgne-20180331ex312d4dcf5.htm EX-31.2 21188
4 EX-32.1 bgne-20180331ex3211318db.htm EX-32.1 13564
  Complete submission text file 0001558370-18-004503.txt   8409498

Data Files

Seq Description Document Type Size
5 EX-101.INS bgne-20180331.xml EX-101.INS 1681469
6 EX-101.SCH bgne-20180331.xsd EX-101.SCH 81818
7 EX-101.CAL bgne-20180331_cal.xml EX-101.CAL 90438
8 EX-101.DEF bgne-20180331_def.xml EX-101.DEF 257139
9 EX-101.LAB bgne-20180331_lab.xml EX-101.LAB 567037
10 EX-101.PRE bgne-20180331_pre.xml EX-101.PRE 513154
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 18819016
SIC: 2834 Pharmaceutical Preparations